Triple therapy with glimepiride in patients with type 2diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: Results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study
- 31 October 2005
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 27 (10), 1535-1547
- https://doi.org/10.1016/j.clinthera.2005.10.017
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Thiazolidinedione Use, Fluid Retention, and Congestive Heart FailureCirculation, 2003
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- UKPDS 28: A Randomized Trial of Efficacy of Early Addition of Metformin in Sulfonylurea-Treated Type 2 DiabetesDiabetes Care, 1998
- Glimepiride, a New Once-Daily Sulfonylurea: A double-blind placebo-controlled study of NIDDM patientsDiabetes Care, 1996
- A Dose-Response Study of Glimepiride in Patients With NIDDM Who Have Previously Received Sulfonylurea AgentsDiabetes Care, 1996
- Development and Validation of the Diabetes Care ProfileEvaluation & the Health Professions, 1996
- A Comparison of Acarbose Versus Metformin as an Adjuvant Therapy in Sulfonylurea-Treated NIDDM PatientsDiabetes Care, 1996
- Symptoms and Well-Being in Relation to Glycemic Control in Type II DiabetesDiabetes Care, 1996
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- Multi-Attribute Health Status Classification SystemsPharmacoEconomics, 1995